A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer.

Authors :: Chiusolo P
Marchetti C
Rossi M
Minnella G
Salutari V
Distefano M
Giammarco S
Metafuni E
Minucci A
Frioni F
Gasbarrino C
Colangelo M
Orteschi D
Fagotti A
Lorusso D
Pagano L
De Stefano V
Scambia G
Sica S
Source :: American journal of hematology [Am J Hematol] 2022 Nov; Vol. 97 (11), pp. E400-E403. Date of Electronic Publication: 2022 Sep 08.
Publication Year :: 2022

Subjects :: Female
Humans
Mutation
Poly(ADP-ribose) Polymerase Inhibitors pharmacology
Poly(ADP-ribose) Polymerase Inhibitors therapeutic use
Leukemia, Myeloid, Acute genetics
Myelodysplastic Syndromes genetics
Ovarian Neoplasms drug therapy
Ovarian Neoplasms genetics
Ovarian Neoplasms pathology

Full Text Access

Tools